Last reviewed · How we verify
NCT03970564
Neck Ultrasound by Respiratory Physicians in Patients With Lung Cancer
trial testing Neck ultrasound guide lymph node sampling in Lung Cancer Metastatic in 30 participants. Completed in 30 May 2018.
21 May 2018
Quick facts
| Lead sponsor | University College Hospital Galway |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 21 October 2016 |
| Primary completion | 21 May 2018 |
| Estimated completion | 30 May 2018 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Neck ultrasound guide lymph node sampling
Conditions studied
- Lung Cancer Metastatic — all drugs for Lung Cancer Metastatic →
- Nodes, Lung — all drugs for Nodes, Lung →
Sponsor
University College Hospital Galway
Who can join
Eligibility, any sex, with Lung Cancer Metastatic or Nodes, Lung. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a study of routine neck ultrasound performed by respiratory physicians in patients with mediastinal lymphadenopathy and suspected lung cancer
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Routine neck ultrasound by respiratory physicians in the diagnosis and staging of patients with lung cancer and mediastinal lymphadenopathy: a prospective pilot study.
Ahmed M, Daneshvar C, Breen D. · · 2020 · cited 9× · PMID 32055635 · DOI 10.1183/23120541.00180-2019
Verify or expand the search:
- PubMed search for NCT03970564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Cancer Metastatic
Currently open trials in the same condition.
- NCT07026110 — Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer · NA · recruiting
- NCT06538012 — TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer · Phase 1, PHASE2 · recruiting
- NCT05537922 — I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy · recruiting
- NCT05452005 — Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer · Phase 1 · recruiting
- NCT05419076 — A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain · Phase 2 · recruiting
Other University College Hospital Galway trials
Trials by the same sponsor.
- NCT07453498 — Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty · NA · recruiting
- NCT06419153 — Evaluating the Efficacy of the Sub-psoas Fascial Plane Block for Post-operative Analgesia Following Hemiarthroplasty · not yet recruiting
- NCT05839704 — A Comparison of Two Regional Techniques for Bariatric Sleeve Gastrectomy · NA · unknown
- NCT05804565 — MetaMet: Bone Cutter Versus Bone Saw for Ray Amputation · NA · unknown
- NCT05124093 — The Effect of High-flow Nasal Oxygen Flow Rate on Gas Exchange During Apnoea · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03970564 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College Hospital Galway
- Last refreshed: 31 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03970564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing